Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Richard J. Pelzl
Observed names:
R Pelzl,
R. Pelzl,
Richard Pelzl
Institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen,
Weill Cornell Medicine
Observed institutions:
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Universitätsklinikum Erlangen,
Weill Cornell Medicine
ORCID:
0009-0004-6219-6608
Observed ORCID:
0009-0004-6219-6608
OpenAlex ID:
A5059614292
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment
2025
·
Richard J. Pelzl
, Giulia Benintende
, et al.
·
Blood
·
14
PDF
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
·
Cancer Discovery
·
2
PDF
10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
2024
·
G Benintende
, R Pelzl
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Supplementary Table 3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S5 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S6 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S7 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 3 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 2 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S6 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Data from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Table 4 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S5 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Methods 1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Supplementary Figure S1 from SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities
2026
·
Benedikt Pelzer
, Cem Meydan
, et al.
Show more works
View as search
Works count:
30
Citation count:
17
H-index:
2
I10-index:
1
Year
Topic
Type